IL‐18 is a key proximal mediator of contact hypersensitivity and allergen‐induced Langerhans cell migration in murine epidermis

Langerhans cells (LC) migrate rapidly from epidermis to lymph node following epicutaneous application of antigen. In this study, we have explored the role of IL‐18, a cytokine with structural similarities to IL‐1β, in murine LC migration and contact hypersensitivity (CHS), which to oxazolone (OX) and 2‐4,dinitrofluorobenzene (DNFB) was suppressed significantly in IL‐18 knockout (IL‐18−/−) mice and could be rescued by local intradermal administration of IL‐18 prior to sensitization, suggesting that the defect in these mice was in the afferent phase of CHS. To determine the effect of IL‐18 on LC migration, mice were treated topically with OX or DNFB, and remaining LC numbers were assessed. A significant decline in remaining epidermal LC occurred in wild‐type (WT) mice but did not occur in IL‐18−/− mice. Sodium lauryl sulfate, a nonantigenic LC migratory stimulus, induced equivalent LC migration in IL‐18−/− and WT mice. In IL‐18−/− mice, IL‐1β and TNF‐α were equally able to mobilize LC from epidermis, indicating that migration in response to these cytokines is not dependent on IL‐18 and suggesting that IL‐18 acts upstream of these cytokines in the initiation of antigen‐induced LC migration. Moreover, IL‐1β but not IL‐18 was able to rescue the defective CHS response observed in caspase‐1−/− mice, which have no functional IL‐1β or IL‐18. These data indicate that IL‐18 is a key proximal mediator of LC migration and CHS, acting upstream of IL‐1β and TNF‐α, and may play a central role in regulation of cutaneous immune responses.

[1]  I. Kimber,et al.  Interleukin 1β and the stimulation of Langerhans cell migration: comparisons with tumour necrosis factor α , 1997, Archives of Dermatological Research.

[2]  R. Gutzmer,et al.  Human keratinocytes respond to interleukin-18: implication for the course of chronic inflammatory skin diseases. , 2005, The Journal of investigative dermatology.

[3]  D. Yoon,et al.  Both E6 and E7 Oncoproteins of Human Papillomavirus 16 Inhibit IL-18-Induced IFN-γ Production in Human Peripheral Blood Mononuclear and NK Cells1 , 2001, The Journal of Immunology.

[4]  J. Reimann,et al.  IL-12/IL-18-Dependent IFN-γ Release by Murine Dendritic Cells1 , 2001, The Journal of Immunology.

[5]  A. Koch,et al.  A Novel Role for Interleukin-18 in Adhesion Molecule Induction through NFκB and Phosphatidylinositol (PI) 3-Kinase-dependent Signal Transduction Pathways* , 2001, The Journal of Biological Chemistry.

[6]  B. Moss,et al.  Molluscum Contagiosum Virus Interleukin-18 (IL-18) Binding Protein Is Secreted as a Full-Length Form That Binds Cell Surface Glycosaminoglycans through the C-Terminal Tail and a Furin-Cleaved Form with Only the IL-18 Binding Domain , 2003, Journal of Virology.

[7]  S. Akira,et al.  IL-18 contributes to the spontaneous development of atopic dermatitis-like inflammatory skin lesion independently of IgE/stat6 under specific pathogen-free conditions , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[8]  A. Enk,et al.  An essential role for Langerhans cell-derived IL-1 beta in the initiation of primary immune responses in skin. , 1993, Journal of immunology.

[9]  E. Shevach,et al.  The functional role of Langerhans cells. , 1980, The Journal of investigative dermatology.

[10]  D. Yoon,et al.  Down modulation of IL‐18 expression by human papillomavirus type 16 E6 oncogene via binding to IL‐18 , 2001, FEBS letters.

[11]  Ping Li,et al.  Characterization of mice deficient in interleukin‐1β converting enzyme , 1997 .

[12]  D. Sauder,et al.  Contribution of Langerhans Cell-Derived IL-18 to Contact Hypersensitivity , 2002, The Journal of Immunology.

[13]  M. Netea,et al.  Interleukin‐18 induces production of proinflammatory cytokines in mice: no intermediate role for the cytokines of the tumor necrosis factor family and interleukin‐1β , 2000, European journal of immunology.

[14]  R. Kamen,et al.  Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock , 1995, Cell.

[15]  I. Kimber,et al.  Differential regulation of epidermal langerhans cell migration by interleukins (IL)-1alpha and IL-1beta during irritant- and allergen-induced cutaneous immune responses. , 2002, Toxicology and applied pharmacology.

[16]  I. Kimber,et al.  Modulation of epidermal Langerhans' cell frequency by tumour necrosis factor-alpha. , 1994, Immunology.

[17]  I. Kimber,et al.  Langerhans cells require signals from both tumour necrosis factor‐α and interleukin‐1β for migration , 1997, Immunology.

[18]  C. Dinarello Interleukin-18 and the pathogenesis of inflammatory diseases. , 2007, Seminars in nephrology.

[19]  C. Dinarello Anti-cytokine therapies in response to systemic infection. , 2001, The journal of investigative dermatology. Symposium proceedings.

[20]  C. Waltzinger,et al.  IL-18 Binding Protein Protects Against Contact Hypersensitivity , 2003, The Journal of Immunology.

[21]  I. Kimber,et al.  Langerhans cell migration in mice requires intact type I interleukin 1 receptor (IL-1RI) function , 1999, Archives of Dermatological Research.

[22]  S. Akira,et al.  Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice. , 1999, Immunity.

[23]  M. Sweet,et al.  Altered immune responses and susceptibility to Leishmania major and Staphylococcus aureus infection in IL-18-deficient mice. , 1999, Journal of immunology.

[24]  T. Kupper,et al.  The interleukin-1 axis and cutaneous inflammation. , 1995, The Journal of investigative dermatology.

[25]  R. Groves,et al.  Human keratinocytes constitutively produce but do not process interleukin‐18 , 2000, The British journal of dermatology.

[26]  T. Mak,et al.  Depressed Langerhans cell migration and reduced contact hypersensitivity response in mice lacking TNF receptor p75. , 1997, Journal of immunology.

[27]  J. Tschopp,et al.  Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. , 1998, Science.

[28]  M. Su,et al.  Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells. , 1998, The Journal of clinical investigation.

[29]  G. Fantuzzi,et al.  Interleukin-18 and Interleukin-1β: Two Cytokine Substrates for ICE (Caspase-1) , 2004, Journal of Clinical Immunology.

[30]  H. Koizumi,et al.  Distribution of IL-18 and IL-18 receptor in human skin: various forms of IL-18 are produced in keratinocytes , 2001, Archives of Dermatological Research.

[31]  C. Griffiths,et al.  Cytokines and Langerhans cell mobilisation in mouse and man. , 2005, Cytokine.

[32]  I. Kimber,et al.  Interleukin (IL)‐18 induces Langerhans cell migration by a tumour necrosis factor‐α‐ and IL‐1β‐dependent mechanism , 2001, Immunology.

[33]  A. Alcamí,et al.  Ectromelia, vaccinia and cowpox viruses encode secreted interleukin-18-binding proteins. , 2000, The Journal of general virology.

[34]  I. Kimber,et al.  Functional Caspase-1 Is Required for Langerhans Cell Migration and Optimal Contact Sensitization in Mice1 , 2001, The Journal of Immunology.

[35]  M. Tsai,et al.  Mast Cell-Associated TNF Promotes Dendritic Cell Migration1 , 2006, The Journal of Immunology.

[36]  A. Enk,et al.  Production of functional IL‐18 by different subtypes of murine and human dendritic cells (DC): DC‐derived IL‐18 enhances IL‐12‐dependent Th1 development , 1998, European journal of immunology.

[37]  B. Nickoloff,et al.  Sunlight-induced basal cell carcinoma tumor cells and ultraviolet-B-irradiated psoriatic plaques express Fas ligand (CD95L). , 1998, The Journal of clinical investigation.

[38]  Griffiths,et al.  Tumour necrosis factor‐α induces Langerhans cell migration in humans , 1999, The British journal of dermatology.

[39]  I. Kimber,et al.  Characteristics and regulation of the expression of interleukin 1 receptors by murine Langerhans cells and keratinocytes , 1998, Archives of Dermatological Research.

[40]  K. Ariizumi,et al.  Interleukin‐1β converting enzyme in murine Langerhans cells and epidermal‐derived dendritic cell lines , 1995 .

[41]  R. Wrench Langerhans cell. , 1981, The Journal of investigative dermatology.